Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
What is the future of life sciences when all the pandemic dust settles? This is what occupies the thoughts of people across pharma, CX, commercial excellence, marketing, medical affairs, and other professional areas. Being in the spotlight during the last year, life sciences seem to be on an unprecedented rise, any minute ready for new […]
In those unique times when patients are eager to take care of their health and cooperate with the pharma, it is important not to miss out on the moment and speak to the audience, using the language that is the most native to them. Not only in terms of translation but using the exact channel […]
The ongoing acceleration of digital technologies and virtual tools urges pharmaceutical companies toward owning a robust omnichannel strategy in place as quickly as possible. Although there has been a lot of talk and variants concerning its implementation, the key point to start with is to create, optimize, and measure an omnichannel strategy in a way […]
COVID-19 has fully revealed the importance of digital transformation for the Pharma industry. Hence the expanding need to create more pharmaceutical content that can be easily adapted to ever-changing market conditions. New realities call for a more personalized, fast, and effective approach to content creation. The combination of a multichannel approach with a modular concept […]
Viseven connects At Viseven, we keep our ears to the ground when it comes to innovations, thus, we never miss the annual Veeva Summit that for many years serves as a great platform for fresh ideas and facilitator of many innovative takes in pharma. This year is not an exception… Lately, the introduction modular approach by Veeva […]
This event took place in April 2019 – and we are proud to have been right in the middle of the discussion! For more information on the insights from global pharma leaders and the panel talk we participated in, take a plunge into the Twitter feed digest we carefully prepared for you. Time to embrace the […]
The global pharmaceutical industry has witnessed a lot of transformations in 2019. In the coming years, we will see even greater global growth sparked by the increasing demand to maintain high levels of innovation. Pharmaceutical companies present a growing number of requests for Creative Agencies to offer HPCs, patients and other stakeholders the most innovative and advanced treatment methods. Viseven partnered with numerous Top Pharmaceutical Companies in 2019. We have carefully analyzed the incoming requests, and we are […]
Global pharma companies appear to hold all the cards in emerging markets — stronger R&D pipelines, higher digital maturity, and the resources to execute at scale. Yet drug accessibility rarely comes down to a single decision at corporate HQ. Behind every market entry lies a more complex reality: localization is not simply translation, and most […]
In pharma, broken processes have a long shelf life. Content workflows are no exception — teams notice the inefficiencies, the duplicated effort, the review cycles that drag on for too long, but the perceived risk of changing anything keeps them from acting on it. The result is a kind of institutional inertia: everyone sees the […]
Would you be okay starting a therapy with a 2.5-star rating for a condition where every moment impacts clinical outcomes? Now imagine coming across a negative patient review, or seeing a trusted HCP publicly question its effectiveness or highlight side effects. Even in oncology, where treatment decisions are guided by HCPs, what patients read online […]
